Trials / Completed
CompletedNCT00380445
Effect of Vildagliptin on Fat and Muscle Metabolism in Patients With Type 2 Diabetes
Effect of Vildagliptin on Adipose Tissue and Skeletal Muscle Metabolism in Obese Patients With Type 2 Diabetes
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 30 Years – 65 Years
- Healthy volunteers
- —
Summary
Please note this study is not being conducted in the United States. The purpose of this study is to test the hypothesis that acute DPP-4 inhibition with vildagliptin improves fat and muscle metabolism in patients with type 2 diabetes mellitus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vildagliptin |
Timeline
- Start date
- 2006-01-01
- Primary completion
- 2007-04-01
- Completion
- 2007-04-01
- First posted
- 2006-09-26
- Last updated
- 2017-02-23
Locations
2 sites across 2 countries: United States, Germany
Source: ClinicalTrials.gov record NCT00380445. Inclusion in this directory is not an endorsement.